Stock Research: Kyowa Hakko Kirin

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Kyowa Hakko Kirin

TYO:4151 JP3256000005
42
  • Value
    67
  • Growth
    15
  • Safety
    Safety
    94
  • Combined
    64
  • Sentiment
    16
  • 360° View
    360° View
    42
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Kyowa Kirin Co Ltd is a Japan-based company that manufactures and sells medical drugs. The company operates in the Pharmaceuticals business segment. It engages in research, development, manufacture, sale, and import & export of prescription pharmaceuticals. It operates in Japan and overseas. In the last fiscal year, the company had a market cap of $8,808 million, profits of $2,309 million, revenue of $3,153 million, and 5669 employees.

more
Index
Nikkei 225
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
67 62 52 45
Growth
15 39 25 79
Safety
Safety
94 79 92 90
Sentiment
16 26 88 23
360° View
360° View
42 23 83 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
22 44 48 65
Opinions Change
50 50 87 39
Pro Holdings
n/a 34 90 18
Market Pulse
20 35 50 37
Sentiment
16 26 88 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
67 62 52 45
Growth
15 39 25 79
Safety Safety
94 79 92 90
Combined
64 37 60 92
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
44 39 36 33
Price vs. Earnings (P/E)
50 60 56 45
Price vs. Book (P/B)
73 62 60 59
Dividend Yield
81 75 60 51
Value
67 62 52 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
32 25 23 62
Profit Growth
38 53 74 45
Capital Growth
10 66 29 62
Stock Returns
53 22 25 75
Growth
15 39 25 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
100 73 79 76
Refinancing
55 51 75 65
Liquidity
96 82 88 86
Safety Safety
94 79 92 90

Similar Stocks

Discover high‑ranked alternatives to Kyowa Hakko Kirin and broaden your portfolio horizons.

Nishi-Nippon Railroad

TYO:9031
Country: Japan
Industry: Railroads
Size: Medium
Full Stock Analysis

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: Large
Full Stock Analysis

Ship Healthcare Holdings

TYO:3360
Country: Japan
Industry: Health Care Distributors
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: